Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Non-coding RNAs are crucial for skin development and health.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Adding a second method to PROTACs could improve cancer treatment.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Mogamulizumab can cause hair loss and skin rashes.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Bioinspired polymers are promising for advanced medical treatments and tissue repair.

HIF-1α is important for hair growth and could be a treatment target for hair loss.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

The combination therapy is effective and well-tolerated for treating esophageal cancer.